Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avicanna Inc T.AVCN

Alternate Symbol(s):  AVCNF

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including oral, sublingual, topical and transdermal delivery. It has developed a pipeline of patent-pending drug candidates that are indication specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain and various neurological disorders. Its first pharmaceutical preparation (Trunerox) is in the drug registration stage in South America. MyMedi.ca is a medical cannabis care platform that serves medical cannabis patients’ needs and enhances the patient's journey.


TSX:AVCN - Post by User

Comment by TommyDon Jan 19, 2022 11:53am
95 Views
Post# 34333035

RE:RE:RE:RE:RE:avicanna road to success

RE:RE:RE:RE:RE:avicanna road to successSetu had more shares than the CEO and his co-founder the last time I checked. It was just under 3m shares. Setu is no longer on SEDI unfortunately. If my memory serves me both Azadian and Perohit issued themselves over 2m founder shares each at $0.0000000002 (you can check Azadian for yourself in SEDI) and then Perohit was paid in cheap shares for his services until the IPO and exercised options which brought his total shares to just under 3m. That's his minimum share count that I am sure about. So Perohit can sell his shares right down to .01 and still have a great ROI. Best of luck!
<< Previous
Bullboard Posts
Next >>